Invention Grant
- Patent Title: GLP-1 receptor agonists and uses thereof
-
Application No.: US16535616Application Date: 2019-08-08
-
Publication No.: US10676465B2Publication Date: 2020-06-09
- Inventor: Gary Erik Aspnes , Scott W. Bagley , John M. Curto , David James Edmonds , Mark E. Flanagan , Kentaro Futatsugi , David A. Griffith , Kim Huard , Yajing Lian , Chris Limberakis , Allyn T. Londregan , Alan M. Mathiowetz , David W. Piotrowski , Roger B. Ruggeri
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Feng Shao
- Main IPC: C07D405/12
- IPC: C07D405/12 ; C07D405/14 ; C07D471/04 ; C07C53/06 ; C07C53/10 ; C07C215/40 ; C07D413/14
Abstract:
Provided herein are 6-carboxylic acids of benzimidazoles and 4-aza-, 5-aza-, and 7-aza-benzimidazoles as GLP-1R agonists, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.
Public/Granted literature
- US20190382388A1 GLP-1 Receptor Agonists and Uses Thereof Public/Granted day:2019-12-19
Information query
